Annemarie Larkin
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
-
- MicroRNA in disease regulation
Papers in
- Oncology 17
- Drug Transport and Resistance Mechanisms 7
- HER2/EGFR in Cancer Research 4
- Pancreatic and Hepatic Oncology Research 3
-
- Protein Degradation and Inhibitors 2
- Co-authors
- Martin Clynes (21 shared papers)Susan Kennedy (14 shared papers)John Crown (8 shared papers)Naomi Walsh (7 shared papers)Lorraine O’Driscoll (4 shared papers)Helena Joyce (3 shared papers)Paul Dowling (7 shared papers)Andrew McCann (2 shared papers)
- Journals
- Journal of Proteome Research (2 papers)International Journal of Cancer (2 papers)Journal of Immunological Methods (2 papers)British Journal of Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- IrelandUnited KingdomGermany
In The Last Decade
Annemarie Larkin
32 papers receiving 759 citations
Peers
Comparison fields: 5 of 83
- Oncology 318
- Cancer Research 148
- Molecular Biology 477
- Hematology 45
- Immunology 72
Countries citing papers authored by Annemarie Larkin
This map shows the geographic impact of Annemarie Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annemarie Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annemarie Larkin more than expected).
Fields of papers citing papers by Annemarie Larkin
This network shows the impact of papers produced by Annemarie Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annemarie Larkin. The network helps show where Annemarie Larkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Annemarie Larkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 76 | |
| 2 | 2009 | 73 | |
| 3 | 2004 | 72 | |
| 4 | 2015 | 65 | |
| 5 | 2012 | 53 | |
| 6 | 2006 | 44 | |
| 7 | 2020 | 33 | |
| 8 | 2012 | 32 | |
| 9 | 2016 | 32 | |
| 10 | 2010 | 27 | |
| 11 | 2014 | 27 | |
| 12 | Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer. | 2004 | 27 |
| 13 | 2014 | 26 | |
| 14 | 2012 | 23 | |
| 15 | 2017 | 21 | |
| 16 | 2017 | 17 | |
| 17 | 2019 | 17 | |
| 18 | 2000 | 17 | |
| 19 | 2011 | 11 | |
| 20 | 2016 | 10 |
About Annemarie Larkin
Annemarie Larkin is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology and Immunology, having authored 32 papers that have together received 770 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Ocular Oncology and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Oncology (318 citations), Cancer Research (148 citations), Molecular Biology (477 citations), Hematology (45 citations) and Immunology (72 citations). Annemarie Larkin has collaborated with scholars based in Ireland, United Kingdom and Germany. Frequent co-authors include Martin Clynes, Susan Kennedy, John Crown, Naomi Walsh, Lorraine O’Driscoll, Helena Joyce, Paul Dowling, Andrew McCann, Niall Swan and Elizabeth Morán. Their work appears in journals such as Journal of Proteome Research, International Journal of Cancer, Journal of Immunological Methods, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.